These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28812438)

  • 1. Acute formaldehyde exposure induced early Alzheimer-like changes in mouse brain.
    Liu X; Zhang Y; Wu R; Ye M; Zhao Y; Kang J; Ma P; Li J; Yang X
    Toxicol Mech Methods; 2018 Feb; 28(2):95-104. PubMed ID: 28812438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. At seeming safe concentrations, synergistic effects of PM
    Liu X; Zhang Y; Luo C; Kang J; Li J; Wang K; Ma P; Yang X
    Oncotarget; 2017 Nov; 8(58):98567-98579. PubMed ID: 29228711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease-Like Pathologies and Cognitive Impairments Induced by Formaldehyde in Non-Human Primates.
    Zhai R; Rizak J; Zheng N; He X; Li Z; Yin Y; Su T; He Y; He R; Ma Y; Yang M; Wang Z; Hu X
    Curr Alzheimer Res; 2018; 15(14):1304-1321. PubMed ID: 30182853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orientin alleviates cognitive deficits and oxidative stress in Aβ1-42-induced mouse model of Alzheimer's disease.
    Yu L; Wang S; Chen X; Yang H; Li X; Xu Y; Zhu X
    Life Sci; 2015 Jan; 121():104-9. PubMed ID: 25497709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formaldehyde, Epigenetics, and Alzheimer's Disease.
    Wang F; Chen D; Wu P; Klein C; Jin C
    Chem Res Toxicol; 2019 May; 32(5):820-830. PubMed ID: 30964647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose total-body carbon-ion irradiations induce early transcriptional alteration without late Alzheimer's disease-like pathogenesis and memory impairment in mice.
    Wang B; Tanaka K; Ji B; Ono M; Fang Y; Ninomiya Y; Maruyama K; Izumi-Nakajima N; Begum N; Higuchi M; Fujimori A; Uehara Y; Nakajima T; Suhara T; Nenoi M
    J Neurosci Res; 2014 Jul; 92(7):915-26. PubMed ID: 24936619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-Plasminogen Activator Attenuates Alzheimer's Disease-Related Pathology Development in APPswe/PS1 Mice.
    ElAli A; Bordeleau M; Thériault P; Filali M; Lampron A; Rivest S
    Neuropsychopharmacology; 2016 Apr; 41(5):1297-307. PubMed ID: 26349911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits.
    Park SH; Kim JH; Choi KH; Jang YJ; Bae SS; Choi BT; Shin HK
    Int J Mol Med; 2013 Mar; 31(3):577-82. PubMed ID: 23314909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of concentrated ambient ultrafine particulate matter on hallmarks of Alzheimer's disease in the 3xTgAD mouse model.
    Herr D; Jew K; Wong C; Kennell A; Gelein R; Chalupa D; Raab A; Oberdörster G; Olschowka J; O'Banion MK; Elder A
    Neurotoxicology; 2021 May; 84():172-183. PubMed ID: 33794265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model.
    Guo C; Zhang S; Li JY; Ding C; Yang ZH; Chai R; Wang X; Wang ZY
    Sci Rep; 2016 Jul; 6():29396. PubMed ID: 27406855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
    Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
    J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease.
    Zhou WW; Lu S; Su YJ; Xue D; Yu XL; Wang SW; Zhang H; Xu PX; Xie XX; Liu RT
    Free Radic Biol Med; 2014 Sep; 74():50-63. PubMed ID: 24960578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.